Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion

被引：0
|
作者：
Zheng-sheng Wu
Chao-qun Wang
Ru Xiang
Xue Liu
Shan Ye
Xue-qing Yang
Gui-hong Zhang
Xiao-chun Xu
Tao Zhu
Qiang Wu
机构：
[1] Anhui Medical University,Department of Pathology
[2] Fudan University,Department of Pathology, Shanghai Medical College
[3] Dongyang People's Hospital,Department of Pathology
[4] The University of Texas MD Anderson Cancer Center,Department of Clinical Cancer Prevention
[5] University of Science and Technology of China,School of Life Science
[6] Anhui Medical University,Department of Pathology
来源：
BMC Cancer | / 12卷
关键词：
Breast cancer; miRNA; miR-133a; Tumor cell invasion; Fascin1; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
    T Chiyomaru
    H Enokida
    S Tatarano
    K Kawahara
    Y Uchida
    K Nishiyama
    L Fujimura
    N Kikkawa
    N Seki
    M Nakagawa
    British Journal of Cancer, 2010, 102 : 883 - 891
  • [22] miR-133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP-14
    Xu, Meng
    Wang, Yu-Zhou
    ONCOLOGY REPORTS, 2013, 30 (03) : 1398 - 1404
  • [23] Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
    Koutsoulidou, Andrie
    Mastroyiannopoulos, Nikolaos P.
    Furling, Denis
    Uney, James B.
    Phylactou, Leonidas A.
    BMC DEVELOPMENTAL BIOLOGY, 2011, 11
  • [24] MIR-145 AND MIR-133A FUNCTION AS TUMOR SUPPRESSORS AND DIRECTLY REGULATE FSCN1 EXPRESSION IN BLADDER CANCER
    Chiyomaru, Takeshi
    Enokida, Hideki
    Tatarano, Shuichi
    Kawahara, Kazuya
    Nishiyama, Kenryu
    Seki, Naohiko
    Nakagawa, Masayuki
    JOURNAL OF UROLOGY, 2010, 183 (04): : E304 - E304
  • [25] miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
    Chiyomaru, T.
    Enokida, H.
    Tatarano, S.
    Kawahara, K.
    Uchida, Y.
    Nishiyama, K.
    Fujimura, L.
    Kikkawa, N.
    Seki, N.
    Nakagawa, M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (05) : 883 - 891
  • [26] MIR-145 AND MIR-133A FUNCTION AS TUMOUR SUPPRESSORS AND DIRECTLY REGULATE FSCN1 EXPRESSION IN BLADDER CANCER
    Chiyomaru, T.
    Enokida, H.
    Tatarano, S.
    Kawahara, K.
    Nishiyama, K.
    Seki, N.
    Nakagawa, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 262 - 262
  • [27] microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation
    Michelle Teodoro Alves
    Izabela Mamede Costa Andrade da Conceição
    Angélica Navarro de Oliveira
    Heloísa Helena Marques Oliveira
    Cintia Esteves Soares
    Adriano de Paula Sabino
    Luciana Maria Silva
    Ricardo Simões
    Marcelo Rizzatti Luizon
    Karina Braga Gomes
    Cardiovascular Toxicology, 2022, 22 : 655 - 662
  • [28] microRNA miR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation
    Alves, Michelle Teodoro
    Costa Andrade da Conceicao, Izabela Mamede
    de Oliveira, Angelica Navarro
    Marques Oliveira, Heloisa Helena
    Soares, Cintia Esteves
    Sabino, Adriano de Paula
    Silva, Luciana Maria
    Simoes, Ricardo
    Luizon, Marcelo Rizzatti
    Gomes, Karina Braga
    CARDIOVASCULAR TOXICOLOGY, 2022, 22 (07) : 655 - 662
  • [29] Chronic angiotensin II administration reduces miR-1 and miR-133a expression in rat heart
    Castoldi, G.
    di Gioia, C.
    Bombardi, C.
    Mancini, M.
    Bonfanti, K.
    Corradi, B.
    Zerbini, G.
    Stella, A.
    JOURNAL OF HYPERTENSION, 2008, 26 : S518 - S518
  • [30] Ursolic Acid Inhibits the Proliferation of Gastric Cancer Cells by Targeting miR-133a
    Xiang, Fenfen
    Pan, Chunying
    Kong, Qianqian
    Wu, Rong
    Jiang, Jiemin
    Zhan, Yueping
    Xu, Jian
    Gu, Xingang
    Kang, Xiangdong
    ONCOLOGY RESEARCH, 2015, 22 (5-6) : 267 - 273
12345